PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-72.63%
G&A reduction while CRON.TO shows 4.56% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-72.63%
Operating expenses reduction while CRON.TO shows 11.36% growth. Joel Greenblatt would examine advantage.
-72.63%
Total costs reduction while CRON.TO shows 6.73% growth. Joel Greenblatt would examine advantage.
105.80%
Interest expense change of 105.80% while CRON.TO maintains costs. Bruce Berkowitz would investigate control.
No Data
No Data available this quarter, please select a different quarter.
72.63%
EBITDA growth exceeding 1.5x CRON.TO's 47.71%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
72.63%
Operating income growth while CRON.TO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
105.80%
Other expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
73.70%
Pre-tax income growth while CRON.TO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
73.70%
Net income growth while CRON.TO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
80.46%
EPS growth while CRON.TO declines. John Neff would investigate advantages.
80.46%
Diluted EPS growth while CRON.TO declines. John Neff would investigate advantages.
33.82%
Share count reduction below 50% of CRON.TO's 25.88%. Michael Burry would check for concerns.
33.82%
Diluted share reduction below 50% of CRON.TO's 25.88%. Michael Burry would check for concerns.